Insider Cluster (2 insiders) ·Filed May 29, 2026

NTRA

Natera, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $627K total
Actionable Insight • Neutral

This is a routine, low-conviction insider sell cluster. The dollar amount is immaterial relative to Natera's $29.1B market cap. No actionable signal for traders — ignore this filing. Monitor for any larger insider sales or changes in the 10b5-1 pattern.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
NTRA ▲ +46.72% at T+60d
NEUTRAL call ✓ call won +46.72% · α vs SPY +45.53% · entry $223.37 → $327.72
Entry anchored
May 28, 2026
via day open
T+1d
-2.04%
call -2.04% · α -2.30%
$218.81
settled 4mo ago
T+5d
-3.61%
call -3.61% · α -1.08%
$215.31
settled 4mo ago
T+20d
+21.91%
call +21.91% · α +23.70%
$272.31
settled 3mo ago
T+60d
+46.72%
call +46.72% · α +45.53%
$327.72
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Natera (President/Chief Business Officer and President of Clinical Diagnostics) sold a combined $627K in open-market sales on May 26, 2026, at ~$202.84/share. The sales are small relative to the $29.1B market cap (0.002%), and the cluster is not amplified by the academic literature for sells. The historical calibration for this ticker shows a 22% win rate at T+20, suggesting prior bullish/neutral calls have underperformed, but this filing is a routine, low-conviction sell cluster.

Key Financial Metrics

Direction
selling
Total Value
$627.0K
Insiders
2

Key Facts

  • Two insiders sold a total of 3,090 shares for $627K in open-market transactions on May 26, 2026.
  • Sales represent ~0.002% of Natera's $29.1B market cap — trivial relative to company size.
  • Both sellers are senior executives (President/CBO and President of Clinical Diagnostics), but the dollar amount is immaterial.
  • No insider buying in the cluster; net direction is selling.
  • Historical performance on NTRA shows a 22% win rate at T+20 across prior reports, but this filing is too small to be informative.

Financial Impact

$627K total insider sales, representing 0.002% of market cap

insider selling volume

Risk Factors

  • Insider selling could accelerate if executives have material non-public negative information, but current volume is too small to indicate this.
  • Natera's historical T+20 win rate of 22% across prior reports suggests the stock has underperformed following past filings, but this filing is too small to be a reliable signal.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
89% bullish (28 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NTRA-1780016732224
35 reports for NTRA
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+1▲ +3.43%Feb 28, 2026
Filters
Rows
Reports for NTRA — sortable, filterable
TypeNow
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 3/10
$328.18 $341.79▲ +4.15%▲ +5.36%$410.35 (+25.04%)
Aug 29, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$321.96 $328.59▼ −2.06%▼ −2.20%$410.35 (−27.45%)
Aug 15, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$314.18 $327.72▲ +4.31%▲ +5.50%$410.35 (+30.61%)
Aug 8, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$318.35 $314.18▼ −1.31%▼ −1.26%$410.35 (+28.90%)
Aug 6, 2026
8w ago
Insider Cluster
BEARISH ★ 4/10
$265.38 $310.78▼ −17.11%▼ −15.89%$410.35 (−54.63%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$269.66 $265.38▼ −1.59%▼ −5.21%$410.35 (+52.17%)
Jul 18, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$262.63 $261.99▼ −0.24%▲ +0.18%$410.35 (+56.25%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$269.83 $264.69▼ −1.90%▼ −0.23%$410.35 (+52.08%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$281.85 $269.83▼ −4.26%▼ −4.13%$410.35 (+45.59%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$281.27 $272.66▼ −3.06%▼ −3.61%$410.35 (+45.89%)
Showing 10 of 35

US Market Status

Market Closed — Opens Mon (65h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 29, 2026